CBT-161
Category: ADCs
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
COA:
Inquire
Targets:
c-Met
Description:
CBT-161 is an ADC that STI-A0602, the monoclonal antibody targeting c-Met, links tubulin inhibitors or DNA damaging agents via C-lock. Preclinical study showed that CBT-161 significantly inhibited tumor growth.
Brife Description:
antitumor drug
MSDS:
Inquire
Application:
antitumor drug
Current Developer:
Sorrento Therapeutics
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 111755-37-4 Microcystin-RR

Microcystin-RR
(CAS: 111755-37-4)

Microcystin-RR inhibits PP1C, PP1γ, and PP2A with Ki values of 0.15, 0.24, and 0.018 nM, respectively.

CAS 1228105-51-8 DM1-SMCC

DM1-SMCC
(CAS: 1228105-51-8)

DM1 with a reactive linker SMCC, which can react with antibody to make antibody drug conjugate, as a potent EGFR inhibitor and it overcomes resistant to EGFR.

Bis-PEG2-NHS Ester
(CAS: 65869-63-8)

A useful protective group in antibody drug conjugates.

Fmoc-VC-PAB-MMAE
(CAS: 1350456-56-2)

Fmoc-Val-Cit-PAB-MMAE is an antibody drug conjugate contained Fmoc-Val-Cit-PAB and MMAE and probably have antineoplastic activity.

CAS 57734-70-0 Bicarphen

Bicarphen
(CAS: 57734-70-0)

Diamine oxidase activator. Na+ channels blocker.

perfluorophenyl 15-(2,5-dioxo-2H-pyrrol-

A useful protective group in antibody drug conjugates.

Bucharidine
(CAS: 25865-94-5)

Quinoline Alkaloid Extracted from Haplophyllum bucharicum

(-)-Scopolamine Perchlorate

Scopolamine, a nonselective muscarinic receptor antagonist, induces distinct behaviors of attenuated motility and C-like hyperactivity.

Quick Inquiry

Verification code

Featured Items